Polymer protection for vaccines and drugs
Retrieved on:
Friday, December 9, 2022
Anaphylaxis, Allergy, Sudden death, Protein, Science and Technology of Advanced Materials, Miho Teramura, Liposome, Water, Science, Antibody, PEG, National Institute of Advanced Industrial Science and Technology, Skin, Nausea, Unconsciousness, Vaccine, Human, MPC, Advanced Materials, Immune system, Research, Risk, Blood, COVID-19, Patient, AIST, STAM, Pharmaceutical industry
TSUKUBA, Japan, Dec 9, 2022 - (ACN Newswire) - A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called anaphylaxis.
Key Points:
- TSUKUBA, Japan, Dec 9, 2022 - (ACN Newswire) - A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called anaphylaxis.
- Until now, the polymer of choice for encasing and delivering vaccines has been poly(ethylene glycol) (PEG).
- The alternative polymer is a form of fatty biomolecule called a lipid, and is conjugated to 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer.
- Provided the animal and subsequent clinical trials go well, the technology should offer opportunities for delivering drugs into the body, in addition to vaccines.